Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Solactis Group

Solactis Group
2013 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Manufacturer of a bio-functional ingredient designed to improve colon and digestive functions. The company's product, Galactofructose, reduces transit time in colon, improves digestive discomfort as well as reinforces immune defences in the digestive system, enabling users to get relief from gastric and other stomach pains and discomfort.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • Domaine de Vilvert - B√Ętiment 325
  • 78352 Jouy-en-Josas
  • France

+33 01 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Solactis Group’s full profile, request a free trial.

Solactis Group Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Solactis Group Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Agoranov Accelerator/Incubator Minority 000 0000 000000 0

Solactis Group Executive Team (1)

Name Title Board
Seat
Contact
Info
Pascal Ronfard Chief Executive Officer